HARVARD BIOSCIENCE, INC. Line of Credit Facility, Maximum Amount Outstanding During Period
HARVARD BIOSCIENCE, INC. (HBIO) reported Line of Credit Facility, Maximum Amount Outstanding During Period of $50.00 million for the 0-month period ending 2013-03-29, per its 10-Q filed 2013-11-08.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod · last filed 2013-11-08
- 2013-03-29: Line of Credit Facility, Maximum Amount Outstanding During Period 0 month $50.00M.
| Period end | Line of Credit Facility, Maximum Amount Outstanding During Period 0 month |
|---|---|
| 2013-03-29 | $50.00M 10-Q · filed 2013-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |